Alfresa Holdings Corporation (JP:2784)
:2784
Want to see JP:2784 full AI Analyst Report?
2784 Stock Chart & Stats
¥2523.00
-¥11.50(-0.53%)
At close: 4:00 PM EST
¥2523.00
-¥11.50(-0.53%)
Day’s Range― - ―
52-Week Range¥1,897.00 - ¥2,685.50
Previous CloseN/A
Volume412.80K
Average Volume (3M)354.02K
Market Cap
¥455.89B
Enterprise Value¥254.23B
Total Cash (Recent Filing)¥180.61B
Total Debt (Recent Filing)¥30.60B
Price to Earnings (P/E)5.4
Beta0.67
Next Earnings
May 19, 2026EPS Estimate
34.67Next Dividend Ex-DateN/A
Dividend Yield2.69%
Share Statistics
EPS (TTM)112.56
Shares Outstanding191,300,000
10 Day Avg. Volume331,350
30 Day Avg. Volume354,016
Financial Highlights & Ratios
PEG Ratio-3.35
Price to Book (P/B)0.81
Price to Sales (P/S)0.13
P/FCF Ratio-36.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,400.00Price Target Upside-4.88% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)163.55
Revenue Forecast (FY)¥3.15T
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetExtremely low leverage and a solid equity ratio give Alfresa durable financial flexibility to fund working capital and logistics needs typical of pharmaceutical distribution. This reduces solvency risk and supports capital allocation for operations, M&A, or infrastructure over the medium term.
Consistent Revenue GrowthMid-single-digit, consistent top-line growth reflects steady demand from hospitals, clinics and pharmacies and underpins scale economics. Predictable revenue helps maintain supplier relationships and supports gradual margin or service expansion across the distribution network over months.
Essential, Diversified Business ModelAs an intermediary in the healthcare supply chain, Alfresa benefits from recurring, non-discretionary demand and adjacency revenue from logistics and fulfillment. Service diversification strengthens customer stickiness and creates structural revenue resilience in an aging-market healthcare sector.
Bears Say
Razor-thin ProfitabilityVery low operating and net margins leave limited buffer against cost inflation, reimbursement or procurement pricing shifts. Sustained thin profitability constrains reinvestment in distribution infrastructure and limits ability to improve returns to shareholders over the medium term.
Weak Cash ConversionA sharp fall to negative free cash flow and poor cash conversion indicate difficulty turning accounting profits into spendable cash. This pressures liquidity for capex, dividends or strategic projects and increases reliance on working capital management or external funding over coming quarters.
Profitability Trend RiskThe noted decline in net margin signals potential rising cost or competitive pressure. If the trend continues it could erode ROE and reduce financial headroom for investments in logistics or tech, impairing long-term competitiveness in the distribution market.
Alfresa Holdings News
2784 FAQ
What was Alfresa Holdings Corporation’s price range in the past 12 months?
Alfresa Holdings Corporation lowest stock price was ¥1897.00 and its highest was ¥2685.50 in the past 12 months.
What is Alfresa Holdings Corporation’s market cap?
Alfresa Holdings Corporation’s market cap is ¥455.89B.
When is Alfresa Holdings Corporation’s upcoming earnings report date?
Alfresa Holdings Corporation’s upcoming earnings report date is May 19, 2026 which is in 21 days.
How were Alfresa Holdings Corporation’s earnings last quarter?
Alfresa Holdings Corporation released its earnings results on Feb 10, 2026. The company reported ¥112.56 earnings per share for the quarter, beating the consensus estimate of ¥65.448 by ¥47.112.
Is Alfresa Holdings Corporation overvalued?
According to Wall Street analysts Alfresa Holdings Corporation’s price is currently Overvalued.
Does Alfresa Holdings Corporation pay dividends?
Alfresa Holdings Corporation pays a Semiannually dividend of ¥34 which represents an annual dividend yield of 2.69%. See more information on Alfresa Holdings Corporation dividends here
What is Alfresa Holdings Corporation’s EPS estimate?
Alfresa Holdings Corporation’s EPS estimate is 34.67.
How many shares outstanding does Alfresa Holdings Corporation have?
Alfresa Holdings Corporation has 191,300,000 shares outstanding.
What happened to Alfresa Holdings Corporation’s price movement after its last earnings report?
Alfresa Holdings Corporation reported an EPS of ¥112.56 in its last earnings report, beating expectations of ¥65.448. Following the earnings report the stock price went down -0.311%.
Which hedge fund is a major shareholder of Alfresa Holdings Corporation?
Currently, no hedge funds are holding shares in JP:2784
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alfresa Holdings Corporation
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
2784 Stock 12 Month Forecast
Average Price Target
¥2,400.00
▼(-4.88% Downside)
Technical Analysis
Medipal Holdings
―
Sundrug Co
―
Sugi Holdings Co
―
Suzuken Co
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---